Mengjuan Yuan

Simvastatin delays castration-resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin-1

Hong Cheng, Wei Sun, Yingying Gao, 2019, International journal of oncology.

Phospholipase C (PLC)ɛ Promotes Androgen Receptor Antagonist Resistance via the Bone Morphogenetic Protein (BMP)-6/SMAD Axis in a Castration-Resistant Prostate Cancer Cell Line

Wei Sun, Yingying Gao, Xiao-hou Wu, 2019, Medical science monitor : international medical journal of experimental and clinical research.

PLCε knockdown overcomes drug resistance to androgen receptor antagonist in castration‐resistant prostate cancer by suppressing the wnt3a/β‐catenin pathway

Jin Yan, Wei Sun, Yu Tang, 2019, Journal of cellular physiology.

PLCε promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathway-mediated glycolysis

Wei Sun, Yingying Gao, Xiao-hou Wu, 2019, Oncology reports.

HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a γ-secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzalutamide in vitro

Wei Sun, Xiao-hou Wu, C. Luo, 2018, International journal of oncology.

Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM

Yingying Gao, Chao-wen Yu, Xiao-hou Wu, 2020, British journal of cancer.

Combination of phospholipase Cε knockdown with GANT61 sensitizes castration-resistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway

Wei Sun, Yingying Gao, Xiao-hou Wu, 2019, Oncology reports.